Isotoxic stereotactic reirradiation for recurrent pelvic cancers
This study highlighted the feasibility of isotoxic pelvic reirradiation and supports further investigation into automation and prediction models to streamline implementation in clinical practice.
Authors
- J. Lilley (ORCID: https://orcid.org/0000-0003-0060-0316)
- Mark E. Harrison (ORCID: https://orcid.org/0000-0002-0729-8407)
- Maxwell Robinson (ORCID: https://orcid.org/0000-0002-0628-1830)
- Christopher O’Hara
- Rasmus Bokrantz
- Philip Camilleri (ORCID: https://orcid.org/0000-0002-2677-5627)
- Stina Svensson (ORCID: https://orcid.org/0000-0003-2808-6072)
- Jakob Ödén (ORCID: https://orcid.org/0000-0002-0644-5022)
- Christopher Pagett (ORCID: https://orcid.org/0000-0001-8096-3875)
- Ane Lindegaard Appelt (ORCID: https://orcid.org/0000-0003-2792-9218)
- Louise Murray (ORCID: https://orcid.org/0000-0003-0658-6455)
- Christopher Thompson (ORCID: https://orcid.org/0000-0001-7447-408X)
- R. Muirhead
Institutions
- University of Leeds (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Mount Vernon Hospital (GB)
- Churchill Hospital (GB)
- St James's University Hospital (GB)
- University of Oxford (GB)
- Mount Vernon Cancer Centre (GB)
- Oxford University Hospitals NHS Trust (GB)
- RaySearch Laboratories (Sweden) (SE)
Publication Details
- Journal
- Physics and Imaging in Radiation Oncology
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1016/j.phro.2025.100889
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00